4 results
Phase 1:The primary objective of this trial is to investigate whether oral esketamine is non-inferior to ECT after eight weeks of individually optimized treatment, in participants with NTRD.Phase 2:To compare the efficacy of maintenance oral…
Primary* To explore the pharmacokinetics of insulin aspart after pulsed intra-vaginal delivery using the MedRing and after subcutaneous injection in women with DM1.Secondary* To assess the safety and short-term tolerability of insulin aspart after…
To assess the impact of adding FFRct analysis to CCTA on the rate of unnecessary invasive coronary angiography (ICA) in patients with stable chest pain that have a >=50% but less than 90% anatomical stenosis on CCTA in any major epicardial…
To investigate whether oral esketamine is non-inferior to ECT in achieving treatment response on depression severity in NTRD.